Literature DB >> 7664490

A type 2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA).

W A Wallace1, E A Ramage, D Lamb, S E Howie.   

Abstract

CFA is an inflammatory condition of the lungs resulting in scarring, pulmonary failure and death. The etiology of the disease is unknown, but the pathogenesis is believed to involve a persistent immunological reaction to unidentified antigen in the lung resulting in tissue damage. Recent advances in our understanding of the immune system have shown that different patterns of stimulatory cytokines are produced at sites of inflammation by a range of cell types. Patterns of cytokine reproduction by inflammatory cells are recognized to be associated with different patterns of immunological response, and these have been described as type 1 (or Th1-like) and type 2 (or Th2-like) on this basis. We have studied cytokine expression in the intestinal inflammatory cell infiltrate in lung tissue from patients with CFA using mRNA in situ hybridization and immunohistochemistry. Our results show that while there is evidence for both a type 1 (characterized by interferon-gamma (IFN-gamma) and type 2 (characterized by IL-4 and IL-5) response present in CFA, the type 2 (or Th2) pattern of cytokines appears to predominate. This would be consistent with a possible role for the humoral immune response in the pathogenesis of this condition. In addition, recent evidence suggests that IL-4 and IFN-gamma may be important regulatory factors for pulmonary fibroblasts. The relative paucity of IFN-gamma may contribute to the excessive fibroblast activation, deposition of collagen and scar formation that occurs in CFA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664490      PMCID: PMC1553239          DOI: 10.1111/j.1365-2249.1995.tb03131.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  Cytokine networks in the regulation of inflammation and fibrosis in the lung.

Authors:  J A Elias; B Freundlich; J A Kern; J Rosenbloom
Journal:  Chest       Date:  1990-06       Impact factor: 9.410

2.  Interferon effects on the growth and division of human fibroblasts.

Authors:  L M Pfeffer; J S Murphy; I Tamm
Journal:  Exp Cell Res       Date:  1979-06       Impact factor: 3.905

3.  Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity.

Authors:  D A Campbell; L W Poulter; G Janossy; R M du Bois
Journal:  Thorax       Date:  1985-06       Impact factor: 9.139

4.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.

Authors:  H Y Reynolds; J D Fulmer; J A Kazmierowski; W C Roberts; M M Frank; R G Crystal
Journal:  J Clin Invest       Date:  1977-01       Impact factor: 14.808

Review 5.  Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

Authors:  R G Crystal; P B Bitterman; S I Rennard; A J Hance; B A Keogh
Journal:  N Engl J Med       Date:  1984-01-19       Impact factor: 91.245

6.  Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features.

Authors:  P L Haslam; C W Turton; B Heard; A Lukoszek; J V Collins; A J Salsbury; M Turner-Warwick
Journal:  Thorax       Date:  1980-01       Impact factor: 9.139

7.  Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins.

Authors:  T R Mosmann; H Cherwinski; M W Bond; M A Giedlin; R L Coffman
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

Review 8.  The Th1-Th2 hypothesis of HIV infection: new insights.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1994-12

9.  Evidence for compartmentalization of functional subsets of CD2+ T lymphocytes in atopic patients.

Authors:  E A Wierenga; M Snoek; C de Groot; I Chrétien; J D Bos; H M Jansen; M L Kapsenberg
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

10.  Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation.

Authors:  M R Duncan; B Berman
Journal:  J Exp Med       Date:  1985-08-01       Impact factor: 14.307

View more
  50 in total

Review 1.  T lymphocyte and fibroblast interactions: the case of skin involvement in systemic sclerosis and other examples.

Authors:  C Chizzolini
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Lung fibrosis.

Authors:  C Fonseca; D Abraham; C M Black
Journal:  Springer Semin Immunopathol       Date:  1999

Review 3.  Fibrotic disease and the T(H)1/T(H)2 paradigm.

Authors:  Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2004-08       Impact factor: 53.106

4.  Modulation of lung inflammation by the Epstein-Barr virus protein Zta.

Authors:  James F Guenther; Jennifer E Cameron; Hong T Nguyen; Yu Wang; Deborah E Sullivan; Bin Shan; Joseph A Lasky; Erik K Flemington; Gilbert F Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-09-03       Impact factor: 5.464

5.  Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.

Authors:  J W Simecka; R J Jackson; H Kiyono; J R McGhee
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

6.  Latent infection by γherpesvirus stimulates profibrotic mediator release from multiple cell types.

Authors:  Joshua S Stoolman; Kevin M Vannella; Stephanie M Coomes; Carol A Wilke; Thomas H Sisson; Galen B Toews; Bethany B Moore
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-10-29       Impact factor: 5.464

Review 7.  Transgenic modeling of transforming growth factor-beta(1): role of apoptosis in fibrosis and alveolar remodeling.

Authors:  Chun Geun Lee; Hye-Ryun Kang; Robert J Homer; Geoffrey Chupp; Jack A Elias
Journal:  Proc Am Thorac Soc       Date:  2006-07

Review 8.  Host responses in tissue repair and fibrosis.

Authors:  Jeremy S Duffield; Mark Lupher; Victor J Thannickal; Thomas A Wynn
Journal:  Annu Rev Pathol       Date:  2012-10-22       Impact factor: 23.472

9.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

Review 10.  Cells and molecules involved in the development of sarcoid granuloma.

Authors:  C Agostini; U Basso; G Semenzato
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.